“May 5, 2003 Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

There are rumors coming from the West Coast that government laboratory regulators are targeting at least one laboratory company for some significant violations. Because allegations of compliance violations by the government can severely damage a lab company’s reputation, there is a tight lid on information by all parties privy to this story.

ADD TO: Lab regulators

If this story is true, it would fulfill a prediction made last year by THE DARK REPORT. During the time when Specialty Laboratories, Inc. was working to resolve its regulatory problems, THE DARK REPORT noted that lab regulators in California have a pattern of major enforcement actions against prominent lab companies and, as a result, would be motivated to look deeper for violations in other lab companies operating in the Golden State.


In what may be a fortuitous piece of luck, cancer researchers discovered a single mouse that was resistant to cancer and have bred offspring that show a genetic resistance to cancer. The work was done at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina. In a study published in the Proceedings of the National Academy of Sciences, Dr. Zheng Cui reported that mice were injected with a particularly aggressive tumor cell. But one mouse, despite repeated injections, never contracted cancer. The other mice in the study developed cancer and died. After breeding the surviving mouse, researchers found about half the offspring showed cancer resistance. They believe this shows the genetic trait is dominant and likely due to one gene.

MORE ON: genetic cancer resistance

These research findings demonstrate how genetic-based technology is opening up new understanding about the mechanisms of diseases like cancer. Research into gene-based resistance is another example of why molecular diagnostics will play a greater role in a variety of clinical applications.


There’s a new lab entrepreneur and a new lab CEO.

  • Sterling Reference Laboratories in Tacoma, Washington is the new name for a lab company involving Evans Calas, its new CEO. Calas, a long-time lab executive in Puget Sound, managed laboratories in the area for International Clinical Labs (ICL), National Health Laboratories, and, most recently was with Dynacare and Laboratory Corporation of America.
  • Alfigen, Inc., the specialty cytogenetic testing company based in Pasadena, California, announced that R. Jeffery Lanzalotta has accepted the position of Chief Executive Officer. Lanza- lotta was part of the executive team at Unilab Corporation, up through its acquisition by Quest Diagnostics Incorporated in recent months.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.